11.9 C
London
Friday, April 26, 2024
HomeCoronavirusZinc-hydroxychloroquine found effective in some COVID-19 patients: study

Zinc-hydroxychloroquine found effective in some COVID-19 patients: study

Date:

Related stories

Rising tuberculosis cases in Leicester spark concern

LEICESTER has the secondhighest rate of tuberculosis (TB) of...

Government bans wet wipes due to their adverse impact on environment

The British government announced on Monday, coinciding with Earth...

Infertility affects 48 million couples globally, environmental disrupters a major contributor

According to the World Health Organization (WHO), infertility is...

World Liver Day 2024: Take care of liver health with these food items

World Liver Day 2024 falls on Friday, April 19th....

Breast cancer may claim million lives per year by 2040: Lancet

BREAST CANCER is now the world’s most common carcinogenic...

The antimalarial drug hydroxychloroquine has shown mixed results against the coronavirus in early studies, but a new paper out of New York suggests combining it with the dietary supplement zinc sulfate could create a more effective treatment.

The research by the NYU Grossman School of Medicine was posted on a medical preprint site on Monday, meaning it hasn’t yet been peer reviewed.

Records of about 900 COVID-19 patients were reviewed in the analysis, with roughly half given zinc sulfate along with hydroxychloroquine and the antibiotic azithromycin.

The other half only received hydroxychloroquine and azithromycin.

Those receiving the triple-drug combination had a 1.5 times greater likelihood of recovering enough to be discharged, and were 44 percent less likely to die, compared to the double-drug combination.

It did not, however, change the average time patients spent in hospital (six days), the time they spent on the ventilator (five days), or the total amount of oxygen required.

Senior investigator and infectious disease specialist Joseph Rahimian told AFP it was the first study to compare the two combinations.

But he cautioned that a controlled experiment would be needed to prove the benefits beyond doubt.

“The next logical step would be to do a prospective study to see if this holds up in people that you give zinc to, and then you watch and compare,” he said.

Hydroxychloroquine has been proposed as a treatment against the SARS-CoV-2 virus because it has antiviral properties that have been proven in lab settings, but not in people.

It interferes with the virus’ ability to enter the cells — and also seems to block them from replicating once they are already inside.

Zinc itself has antiviral properties and past research has suggested it may reduce the time people suffer from common colds.

Rahimian said that it may be that when used to treat coronavirus patients, it is the zinc that does the heavy lifting and is the primary substance attacking the pathogen.

Hydroxychloroquine, on the other hand, acts as an agent that transports the zinc into cells, increasing its efficacy, he suggested.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories